U.S. Senate Passes Two Major Bills to Combat Alzheimer’s Disease

WASHINGTON, D.C. — The U.S. Senate passed two key bills aimed at reinforcing Alzheimer’s disease as a national priority and increasing accountability in federal funding.

Reauthorization of the National Alzheimer’s Project Act (NAPA), a major priority of UsAgainstAlzheimer’s, approaches Alzheimer’s disease as a public-health crisis. Specifically, NAPA aims to prevent and effectively treat Alzheimer’s and related dementias by 2035 while expanding support for people living with the disease and their families, while increasing public awareness.

The Alzheimer’s Accountability and Investment Act would enhance accountability and transparency in federal funding for Alzheimer’s by requiring the National Institutes of Health to submit an annual budget and estimated personnel needed to do the work associated with NAPA.

“These two bills are incredibly important to the work we are doing to end the scourge of Alzheimer’s,” said George Vradenburg, chair and co-founder of UsAgainstAlzheimer’s. “By reinforcing our national commitment to fighting this crisis and requiring accountability for every federal dollar spent, these bills help ensure that our country will keep its foot on the gas to stop this disease. We look forward to working with Health and Human Services on establishing new national goals for 2035 and engaging the business community in those conversations so we can address the enormous economic impact of Alzheimer’s.”